Osaic Holdings
PMVP icon

Osaic Holdings’s PMV Pharmaceuticals PMVP Stock Holding History

Osaic Holdings’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,320
Closed -$1.99K – 7657
2024
Q4 		$1.99K Hold
1,320
– – ﹤0.01% 6609
2024
Q3 		$1.97K Buy
+1,320
New +$2.04K ﹤0.01% 6618
2024
Q1 		– Sell
-15
Closed -$92 – 7353
2023
Q4 		$92 Sell
15
-268
-95% -$709 ﹤0.01% 7117
2023
Q3 		$1.74K Buy
283
+52
+23% +$358 ﹤0.01% 6677
2023
Q2 		$1.44K Hold
231
– – ﹤0.01% 6767
2023
Q1 		$1.1K Sell
231
-28
-11% -$197 ﹤0.01% 6918
2022
Q4 		$2K Sell
259
-59
-19% -$629 ﹤0.01% 6692
2022
Q3 		$4K Hold
318
– – ﹤0.01% 6506
2022
Q2 		$4K Sell
318
-32
-9% -$466 ﹤0.01% 6615
2022
Q1 		$7K Buy
350
+24
+7% +$423 ﹤0.01% 6339
2021
Q4 		$8K Buy
326
+39
+14% +$942 ﹤0.01% 6407
2021
Q3 		$9K Buy
287
+57
+25% +$1.82K ﹤0.01% 6278
2021
Q2 		$8K Buy
230
+18
+8% +$601 ﹤0.01% 6203
2021
Q1 		$7K Sell
212
-6
-3% -$237 ﹤0.01% 6037
2020
Q4 		$13K Buy
+218
New +$8.55K ﹤0.01% 5404

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Osaic Holdings's PMVP Position: Q1 2025 in Review

Osaic Holdings sold out of PMV Pharmaceuticals (PMVP) in Q1 2025, closing a stake of 1,320 shares — an estimated $1.99K sold.

Osaic Holdings first reported a position in PMVP in Q4 2020 and held it in 15 quarters. The position peaked at $13K in Q4 2020. 55 funds tracked by Wall St. Rank hold PMVP as of Q1 2025.

  • Osaic Holdings reported no remaining PMV Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Osaic Holdings sold 1,320 PMV Pharmaceuticals shares in Q1 2025, an estimated $1.99K.
  • Osaic Holdings first reported a position in PMV Pharmaceuticals in Q4 2020 and held it in 15 quarters.
  • Osaic Holdings's PMV Pharmaceuticals position peaked at $13K in Q4 2020.
  • 55 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.